Related references
Note: Only part of the references are listed.
Meeting Abstract
Oncology
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma (HCC).
Mairead Geraldine McNamara et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Share Paper
